endralazine

0 marketed 1 in Phase 2

This page covers all endralazine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-dependent L-type calcium channel subunit alpha-1C.

Targets

Voltage-dependent L-type calcium channel subunit alpha-1C

Phase 2 pipeline (1)

Patent intelligence